Neuroinflammation in Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disease associated with human aging. Ten percent of individuals over 65 years have AD and its prevalence continues to rise with increasing age. There are currently no effective disease modifying treatments for AD, resulting in increasingly large socioe...
Main Authors: | Isaac G. Onyango, Gretsen V. Jauregui, Mária Čarná, James P. Bennett, Gorazd B. Stokin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/5/524 |
Similar Items
-
Function of the microglia in neuroinflammation of Alzheimer's disease:a brief review
by: WANG Yuan-zhuo, ZHENG Qing-yue, ZHANG Han-lin, QIU Wen-ying, WANG Tao, MA Chao
Published: (2022-08-01) -
Inflammasome signaling is dispensable for ß-amyloid-induced neuropathology in preclinical models of Alzheimer’s disease
by: Sahana Srinivasan, et al.
Published: (2024-01-01) -
Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease
by: Akira Sobue, et al.
Published: (2023-05-01) -
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease
by: Eunshil Lee, et al.
Published: (2025-01-01) -
Irisin Attenuates Neuroinflammation Targeting the NLRP3 Inflammasome
by: Francesca Martina Filannino, et al.
Published: (2024-11-01)